ArticleFrontiers in pharmacology2026

Zolbetuximab-associated adverse event reporting signals in gastric cancer: a FAERS disproportionality analysis.

Jingshun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.